Literature DB >> 3321211

Rubella virus and arthritis.

C A Smith1, R E Petty, A J Tingle.   

Abstract

Rubella virus and the rubella virus vaccine are relatively common causes of acute arthralgias and occasionally objective arthritis. Rarely, chronic or relapsing joint syndromes may follow exposure to this virus or vaccine. This article will focus on the virus and its clinical illness. Major emphasis then will be given to the resulting arthritis syndromes and to consideration of the possible pathogenetic mechanisms of the joint manifestations.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3321211

Source DB:  PubMed          Journal:  Rheum Dis Clin North Am        ISSN: 0889-857X            Impact factor:   2.670


  4 in total

1.  A Case Report of Secondary Syphilis Co-Infected with Measles: A Diagnostic Dilemma with Fever and Rash.

Authors:  Hisham Ahmed Imad; Ploi Lakanavisid; Phimphan Pisutsan; Kentaro Trerattanavong; Thundon Ngamprasertchai; Wasin Matsee; Watcharapong Piyaphanee; Pornsawan Leaungwutiwong; Wang Nguitragool; Emi E Nakayama; Tatsuo Shioda
Journal:  Trop Med Infect Dis       Date:  2022-05-09

2.  Epidemiology of rubella infections in Austria: important lessons to be learned.

Authors:  B Falkensammer; G Walder; D Busch; A Giessauf; M Dierich; R Würzner
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-05-18       Impact factor: 5.103

3.  Acute arthropathy in patients with rash diseases: a comparative study.

Authors:  Solange Artimos de Oliveira; Luiz Antonio Bastos Camacho; Letícia Fernandes Bruno; Rodrigo Coimbra de Gusmão; Antonio Carlos de Medeiros Pereira; Luis Guillermo Coca Velarde; Marilda Mendonça Siqueira
Journal:  Clin Rheumatol       Date:  2009-05-05       Impact factor: 3.650

Review 4.  Virally associated arthritis 2008: clinical, epidemiologic, and pathophysiologic considerations.

Authors:  Dimitrios Vassilopoulos; Leonard H Calabrese
Journal:  Arthritis Res Ther       Date:  2008-09-18       Impact factor: 5.156

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.